Introduction
Oligodendrocytes, the myelinating cells of the central nervous system (CNS), arise during development from glial progenitor cells known as 0-2A progenitors (Raff et al. 1983) . In vivo, the time course of oligodendrocyte production is precisely controlled. In the embryonic rat optic nerve, 0-2A progenitors proliferate and do not differentiate; then, starting on the day of birth, some 0-2 A progenitors stop dividing and differentiate into oligoden drocytes while the others continue to divide. Proliferation and oligodendrocyte differentiation continue together in the nerve for several weeks after birth (Miller et al. 1985) . However, when embryonic or postnatal optic nerve cells are dissociated and cultured in medium containing low concentrations (0.5 %) of fetal calf serum (FCS), nearly all the 0-2A progenitors stop dividing straightaway and differentiate prematurely into oligodendrocytes (Raff et al. 1983; Raff et al. 1985) . Thus, there must be environmental signals present in vivo, but missing in vitro, that are required to keep 0-2A progenitors dividing and delay the onset of oligodendrocyte differentiation. We are trying to identify these environmental factors and understand how they regulate the timing of oligodendrocyte differentiation during development. Platelet-derived growth factor (PDGF), in concert with other polypeptide growth factors, probably plays an important role in this process (reviewed by Richardson et al. 1990; see below) .
The earliest committed 0-2A lineage cells probably originate in the germinal zones around the ventricles (subventricular zones) and subsequently migrate away from there, maturing as they go, to populate the rest of the CNS with oligodendrocytes (Small et al. 1987; Levine and Goldman, 1988a,b; Reynolds and Wilkin, 1988) . To identify environmental factors that might influence the step-wise development of 0-2A lineage cells in vivo and relate this to studies in vitro, we need to establish what polypeptide growth factors are available, and which of these the 0-2A progenitors can respond to, at each stage of their progress from immature neuroepithelial cell to mature oligodendrocyte'. With this aim in mind, we have started to map the distribution of PDGF and its receptors in the developing CNS by in situ hybridization and immunohistochemistry; our early progress and con clusions are summarized below.
PDGF, PDGF receptors and oligodendrocyte development
There is now strong evidence that platelet-derived growth factor (PDGF) plays an important role in controlling the proliferation and differentiation of 0-2A progenitor cells during development. 0-2A progenitor cells freshly isolated from newborn rat optic nerves possess cell-surface recep tors for PDGF (Hart et al. 1989a; McKinnon et al. 1990) , and PDGF is a potent mitogen for 0-2A progenitors in vitro ( Noble et al. 1988 ; Richardson et al. 1988) . Further more, PDGF can recreate the normal timing of oligoden drocyte development in vitro ( Raff et al. 1988 ). For example, if optic nerve cells from E17 rats are cultured in chemically defined medium containing PDGF, the 0 -2 A progenitors continue to divide for some time, and oligodendrocytes do not appear until the fourth day in culture, corresponding to the day of birth in vivo (E21). If E18 optic nerve cells are cultured in the same way, the first oligodendrocytes appear on the third day in vitro, and so on. As PDGF mRNA ( Richardson et al. 1988; Pringle et al. 1989) Fig. 1 . PDGF and its receptors. PDGF is a dimer of A and B chains, with the structure AA, BB or AB. PDGF oe-receptor subunits (PDGF-aR) can bind both PDGF A and B chains, while PDGF /5-receptor subunits (PDGF-/3R) can bind only PDGF B chains. Consequently, PDGF-AA can cross-link and activate only PDGF-aR, while PDGF-BB can activate both PDGF-aR and PDGF-/JR. According to this simple scheme, PDGF-AB should be able to cross-link two A chains, or one A and one B chain; therefore, PDGF-AB might be able to act as a receptor antagonist for cells with only PDGF-/2R, since it should be able to bind to, but not dimerize, PDGF-/5R (Heldin and Westermark, 1989) . Recently, however, evidence has been presented that PDGF-AB can activate cells with only PDGF-/ÎR (Drozdoff and Pledger, 1991) . coexist in the same dish. This suggests that the decision to differentiate is cell-autonomous and does not depend on timed signals from other cells. Thus, in order to under stand how oligodendrocyte differentiation is timed, we need to know why proliferating 0 -2 A progenitor cells eventually lose their ability to divide in response to PDGF. In principle, this loss of responsiveness to PDGF could be caused by a loss of PDGF receptors at the cell surface, a block in one of the intracellular second messenger systems that transduces the mitogenic signal, or a deficiency in part of the cell's replication machinery. PDGF receptor loss does not seem to be the key, because newly-formed, post-mitotic oligodendrocytes seem to have numbers of PDGF receptors similar to the proliferating 0 -2 A progeni tors that gave rise to them (Hart et al. 1989a) . PDGF receptors are eventually lost from maturing oligodendro cytes, but this is a consequence of differentiation, not the cause. The PDGF receptors on newly-formed oligodendro cytes are functional, and linked into at least part of the signal transduction apparatus, because PDGF stimulation of young oligodendrocytes in vitro leads to elevation of cytosolic Ca2+ (Hart et al. 19896) , and activation of the proto-oncogene products c-Jun and c-Fos in the nucleus (Hart et al. 1990 and unpublished data). Thus, it appears that the mitotic block that develops in an 0 -2 A progenitor cell, causing it to drop out of division and differentiate into an oligodendrocyte, lies downstream of nuclear proto oncogene activation or, alternatively, in an unidentified, parallel signalling pathway. The cells were dissociated with trypsin, macrophages were allowed to attach to uncoated bacterial Petri dishes for a short time and the remaining cells were subjected to immunoselection, first with an anti-GC antibody to remove unwanted oligodendrocytes, and then with antibody A2B5 to positively select 0-2A progenitors. Cells were removed from the final panning dish with trypsin, and plated in 60 mm dishes in defined medium containing PDGF-AA and bFGF (both lO n gm l" 1) and 0.5% FCS. They were maintained like this for 2 -3 days, after which time the cells were 3=97 % A2B5+. The culture medium was removed and replaced with fresh medium lacking PDGF and bFGF and, at the indicated times after growth factor withdrawal, the cells were harvested and total cellular RNA isolated. The RNA (5 ¿tg/lane) was transferred to nylon membrane and hybridized with a 32P-labelled SCIP DNA probe. The membrane was subsequently stripped and rehybridized with a CNP probe and a pyruvate kinase (PK) probe (as a control for gel loading). The figure is a composite of three autoradiographs. SCIP mRNA is high in 0-2A progenitors maintained in a proliferating state with PDGF-AA and bFGF but, in this experiment, SCIP mRNA declined to background levels within 24 h after removal of growth factors.
Regulation

Sources of PDGF in the CNS; neurons versus
Other experiments (not shown) demonstrated that downregulation of SCIP mRNA is complete by 6 h after growth factor withdrawal. mRNA encoding CNP, a marker of oligodendrocyte differentiation, is up-regulated following the removal of PDGF and bFGF.
nerve to degenerate rapidly. The number of oligodendro cytes and their progenitors present in the nerve stump one week later was reduced more than eight-fold compared to untransected nerves, whereas the number of type-1 astrocytes (which belong to a different cell lineage) was reduced less than two-fold ( David et al. 1984) . Surpris ingly, despite the large decrease in the population of oligodendrocyte lineage cells, the mitotic index of these cells did not differ significantly between transected and untransected nerves. This was interpreted to mean that 0 -2 A progenitors depend on axons, not for proliferation p er se, but rather for survival. These experiments suggested that intact axons are not obligatory for mitogenic stimulation of 0 -2 A progenitors in the optic nerve, suggesting instead that glial cells in the nerve might be the source of the mitogen(s). Support for this latter view came from the finding that cultured astrocytes from rat cerebral cortex, which resemble type-1 astrocytes . 4 ). They continue to increase in number until at least P10, especially in the developing subcortical white matter and corpus callosum, before declining again in the adult. This is similar to the behaviour of a class of presumptive 0-2A lineage cells described by Levine and Goldman (1988a) , who studied oligodendrocyte development in the rat forebrain using antibodies against GD3 and carbonic anhydrase (CA). In contrast, most cortical neurons are formed before birth. Moreover, cortical neurons in the postnatal cortex are arranged in a series of discrete lamellae parallel to the pial surface, whereas PDGF-aR+ cells never show any signs of stratification, reinforcing the view that PDGF-aft is expressed on glial cells, not neurons. (4) The PDGF-aR hybridization signal is invariably associated with cells that possess small, round, densely-staining nuclei that are characteristic of glial cells. Conversely, where neurons can be unambiguously identified by virtue of their position and/or nuclear morphology (e.g. retinal ganglion neurons, cerebellar Purkinje neurons, hippocampal neurons), these cells are always negative for PDGF-aR. If it is true that PDGF-aR is restricted to the 0-2A lineage, then what might we deduce about the develop ment of the 0-2A lineage from our in situ studies? We first see small numbers of PDGF-aR+ cells in the anterior forebrain at E14-E16. These cells first appear outside the subventicular germinal zones, suggesting that PDGF-aR is not expressed by the earliest committed 0-2A lineage cells but is up-regulated after, or shortly before they leave the germinal zones and migrate away towards their final destinations.
Distribution of cells expressing PDGF-«R and SCIP in the developing CNS
We also considered the possibility that SCIP might specifically mark early stages of the 0-2A lineage in the CNS, since SCIP is expressed highly in proliferating 0-2A progenitors in vitro, but is strongly down-regulated when these cells are induced to differentiate by withdrawing growth factors (see above). However, in situ hybridization of developing rat CNS tissue (Fig. 4) gives no indication that SCIP is restricted to the 0-2A lineage; on the contrary, SCIP seems to be expressed in many developing neurons and even some mature neurons. For example, SCIP is expressed in a broad band of cells in the developing retina at E16 (not shown); these cells cannot belong to the 0-2A lineage because the rat retina is unmyelinated. In the anterior forebrain, SCIP mRNA is present at E16 in a broad band of cells in the subventricular zones inferior and lateral to the lateral ventricles. With increasing age, the zone of SCIP expression expands into the subventricular zone superior to the ventricles (Fig. 4) , and then moves outwards towards the pial surface. By PO, the zone of SCIP expression lies just beneath the pial surface, superior to the developing subcortical white matter (see Fig. 4 ). This pattern of expression suggests that SCIP is expressed in a population of migrating neuronal progenitors in the cortex. By P10, SCIP mRNA is no longer detected in the cortex, but a strong signal appears in hippocampal neurons in regions CA1 and CA2. An intense SCIP signal is also observed at P5 in the trigeminal nerve, up to but not beyond the point where it enters the CNS. This presum ably represents the point where Schwann cells give way to oligodendrocytes. Surprisingly, we have been unable to detect SCIP+ cells in the P5 optic nerve, even though SCIP mRNA can be detected in the nerve at this age on Northern blots (Monuki et al. 1989) . We conclude that several, perhaps many cell lineages in the PNS and CNS express SCIP at some point in their development, perhaps associated with the transition from proliferation to differentiation. 0-2A progenitors presumably do express SCIP in vivo but at a level that is below the detection limit of our in situ procedure, at least in outlying regions of the CNS such as the optic nerve. Clearly, SCIP is not a useful marker for the 0-2A lineage in situ.
What is the role of FGF in 0-2A lineage development?
FGF is reported to be mitogenic for 0-2A lineage cells in culture (Eccleston and Silberberg, 1985; Saneto and deVellis, 1985; McKinnon et al. 1990 ), although there is at least one other report that contradicts this (Hunter and Bottenstein, 1990) . This disagreement may result from differences in the purity and source of the 0-2A progenitor cells and/or the particular preparation of FGF. Recently, it was found that the combination of bFGF and PDGF has a striking cooperative effect, stimulating prolonged pro liferation of 0-2A progenitors in the apparent absence of oligodendrocyte differentiation (Bogler et al. 1990) . bFGF is present in the developing and mature CNS (Gospodarowicz, 1984; Gonzalez et al. 1990) ; by immunohistochemistry it appears to be present in the cell bodies of neurons (Janet et al. 1988) . However, it is not known whether bFGF can be released from neurons, or any living cell, since its polypeptide precursor lacks a recognizable signal for entry into the constitutive secretory pathway. In any event, it seems unlikely that bFGF and PDGF act together on 0-2A progenitors in the postnatal optic nerve, or other developing white matter tracts, otherwise oligodendrocyte differentiation would presumably be inhibited. Perhaps bFGF is released only from dying cells as a response to CNS injury. Alternatively, FGF may be released from living cells by an unconventional mechan ism, but its biological effects restricted to a compartment(s) of the CNS where oligodendrocytes are not required. For example, receptors for bFGF (bFGF-R) might normally be expressed on 0-2A lineage cells only at an early stage in their development, perhaps on a population of self-renewing cells near the ventricles whose function is to generate a steady stream of migrating 0-2A progenitors or pre-progenitors. The migrating cells might normally lose bFGF-R as they move away from the subventricular layer, perhaps gaining PDGF-arR in their place. This hypothesis would fit with the observations that cells expressing bFGF-R are found predominantly in the subventricular zones of developing rat and chicken brain (Heuer et al. 1990; Wanaka, Johnson and Milbrandt, 1990) , whereas putative 0-2A lineage cells expressing PDGF-aR are located mainly outside of the subventricular zone (our results, see above). To explain why 0-2A progenitors from the optic nerve respond to bFGF in vitro, we would also have to speculate that bFGF-R is inappro priately up-regulated when the cells are dissociated and placed in culture. More needs to be learned about the FGF receptors on 0-2A lineage cells in vitro and in vivo, and the availability of FGF in the CNS, before this and other possibilities can be fully explored.
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